期刊
ONCOIMMUNOLOGY
卷 1, 期 1, 页码 67-70出版社
TAYLOR & FRANCIS INC
DOI: 10.4161/onci.1.1.18068
关键词
CD73; adenosine; tumor immunotherapy; metastasis; adenosine receptors
资金
- National Institutes of Health [CA149669]
- Ovarian Cancer Research Foundation Founds [LT/UTHSC/01.2011]
- CTSA grant [UL1RR025767]
- Cancer Therapy and Research Center [2P30 CA054174-17]
Evading immune destruction has recently emerged as one of the hallmarks of cancer. 1 The identification of multiple mechanisms of tumor-induced immune evasion provides an array of novel targets for new cancer therapies. 2 Given the well-established immune effects of CD39/CD73 and the A(2A) adenosine receptor (A(2A)R) on cancer growth and metastasis, the phosphohydrolysis of extracellular ATP to adenosine can now be viewed as one of the most important immunosuppressive regulatory pathways in the tumor microenvironment. The focus of this review is to specifically discuss the newly available experimental evidence demonstrating a pivotal role of tumor and host CD73-mediated adenosinergic effects on tumor growth and metastasis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据